ClinicalTrials.Veeva

Menu

CT Abnormalities Evocative of Lung Infection Are Associated With Lower 18F-FDG Uptake in Confirmed COVID-19 Patients

C

Central Hospital, Nancy, France

Status

Completed

Conditions

Presence of COVID-19 Compatible CT Abnormalities

Treatments

Diagnostic Test: PET-CT of 18F-FDG

Study type

Observational

Funder types

Other

Identifiers

NCT04512118
2020PI153

Details and patient eligibility

About

CT signs that are evocative of lung COVID-19 infections have been extensively described, whereas 18F-FDG-PET signs have not. Our current study aimed to identify specific COVID-19 18F-FDG-PET signs in patients that were (i) suspected to have a lung infection based on 18F-FDG-PET/CT recorded during the COVID-19 outbreak and (ii) whose COVID-19 diagnosis was definitely established or excluded by appropriate viral testing.

Enrollment

22 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patient coming to nuclear medicine for 18F-flurodesoxyglucose (FDG) positron emission tomography computed tomography (PET-CT) with suspicion of lung involvement
  • patient affiliated to a social security scheme or equivalent
  • adult patient having been informed of the study

Exclusion criteria

  • patient with a negative covid 19 test

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems